Loading markets…

Rhythm Pharmaceuticals, Inc. (RYTM) forecast

Rhythm Pharmaceuticals, Inc. (RYTM) forecast: price $89.56, trailing P/E -28.50, forward P/E 34.33. How to read the street's path.

$89.56Price
$6.17BMarket cap
-28.50P/E ?
34.33Forward P/E ?
0.00%Dividend yield ?

The live RYTM price is $89.56. Trailing P/E is -28.50 and forward P/E is 34.33. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the RYTM forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full RYTM quote · Dividends · Price prediction · Academy

Questions

What is RYTM's forward P/E?

The latest forward P/E on Stocklytics is 34.33, against a trailing P/E of -28.50 and a price of $89.56.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.